Viatris Inc. (LON:0A5V)

Market Cap	10.62B
Revenue (ttm)	11.23B
Net Income (ttm)	-659.03M
Shares Out	n/a
EPS (ttm)	-0.55
PE Ratio	n/a
Forward PE	n/a
Dividend	0.37 (3.40%)
Ex-Dividend Date	Nov 22, 2024

Volume	12,820
Average Volume	8,384
Open	10.92
Previous Close	10.86
Day's Range	10.92 - 11.10
52-Week Range	7.89 - 10.81
Beta	n/a
RSI	51.15
Earnings Date	Feb 27, 2025

About Viatris

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agent...

• Industry: Pharmaceutical Preparations
• Founded: 1961
• Employees: 38,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5V

Financial Performance

In 2023, Viatris's revenue was $15.43 billion, a decrease of -5.14% compared to the previous year's $16.26 billion. Earnings were $54.70 million, a decrease of -97.37%.

Financial numbers in USD